Simplex Trading’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-34,600
| Closed | -$156K | – | 8376 |
|
|
2025
Q3 | $156K | Buy |
+34,600
| New | +$102K | ﹤0.01% | 5223 |
|
|
2025
Q2 | – | Sell |
-1,100
| Closed | -$4K | – | 8503 |
|
|
2025
Q1 | $4K | Sell |
1,100
-1,900
| -63% | -$8.56K | ﹤0.01% | 7627 |
|
|
2024
Q4 | $14K | Buy |
3,000
+2,000
| +200% | +$13.5K | ﹤0.01% | 6925 |
|
|
2024
Q3 | $7K | Buy |
1,000
+600
| +150% | +$4.36K | ﹤0.01% | 7387 |
|
|
2024
Q2 | $2K | Sell |
400
-4,700
| -92% | -$43.7K | ﹤0.01% | 8207 |
|
|
2024
Q1 | $72K | Buy |
5,100
+4,870
| +2,117% | +$74.1K | ﹤0.01% | 5920 |
|
|
2023
Q4 | $1K | Buy |
+230
| New | +$2.1K | ﹤0.01% | 8421 |
|
|
2022
Q2 | – | Sell |
-4,950
| Closed | -$64K | – | 9829 |
|
|
2022
Q1 | $64K | Sell |
4,950
-12,410
| -71% | -$182K | ﹤0.01% | 6787 |
|
|
2021
Q4 | $305K | Buy |
17,360
+1,430
| +9% | +$28.6K | ﹤0.01% | 4539 |
|
|
2021
Q3 | $573K | Hold |
15,930
| – | – | ﹤0.01% | 3880 |
|
|
2021
Q2 | $557K | Buy |
15,930
+15,769
| +9,794% | +$849K | ﹤0.01% | 3975 |
|
|
2021
Q1 | $1.59M | Buy |
161
+150
| +1,364% | +$18K | ﹤0.01% | 1878 |
|
|
2020
Q4 | $122K | Buy |
11
+4
| +57% | +$495 | ﹤0.01% | 5230 |
|
|
2020
Q3 | $72K | Sell |
7
-2
| -22% | -$300 | ﹤0.01% | 5245 |
|
|
2020
Q2 | $194K | Sell |
9
-5
| -36% | -$886 | ﹤0.01% | 4037 |
|
|
2020
Q1 | $137K | Buy |
14
+3
| +27% | +$350 | ﹤0.01% | 4032 |
|
|
2019
Q4 | $123K | Sell |
11
-9
| -45% | -$793 | ﹤0.01% | 4292 |
|
|
2019
Q3 | $110K | Buy |
20
+19
| +1,900% | +$2.14K | ﹤0.01% | 4216 |
|
|
2019
Q2 | $5K | Hold |
1
| – | – | ﹤0.01% | 6429 |
|
|
2019
Q1 | $3K | Sell |
1
-14
| -93% | -$566 | ﹤0.01% | 6630 |
|
|
2018
Q4 | $45K | Buy |
15
+13
| +650% | +$529 | ﹤0.01% | 4616 |
|
|
2018
Q3 | $12K | Buy |
+2
| New | +$112 | ﹤0.01% | 6294 |
|
|
2018
Q2 | – | Sell |
-2
| Closed | -$3K | – | 7294 |
|
|
2018
Q1 | $3K | Buy |
+2
| New | +$125 | ﹤0.01% | 4932 |
|
|
2017
Q1 | – | Sell |
-1
| Closed | -$1K | – | 6058 |
|
|
2016
Q4 | $1K | Sell |
1
-5
| -83% | -$163 | ﹤0.01% | 5287 |
|
|
2016
Q3 | $12K | Sell |
6
-9
| -60% | -$341 | ﹤0.01% | 3435 |
|
|
2016
Q2 | $30K | Buy |
15
+4
| +36% | +$181 | ﹤0.01% | 2513 |
|
|
2016
Q1 | $13K | Buy |
+11
| New | +$614 | ﹤0.01% | 3199 |
|
|
2015
Q4 | – | Sell |
-30
| Closed | -$148K | – | 5296 |
|
|
2015
Q3 | $148K | Sell |
30
-32
| -52% | -$4.09K | 0.01% | 1108 |
|
|
2015
Q2 | $325K | Buy |
+62
| New | +$20.9K | 0.03% | 541 |
|
Simplex Trading's ADVM Position: Q2 2025 in Review
Simplex Trading sold out of Adverum Biotechnologies (ADVM) in Q2 2025, closing a stake of 4,313 shares — an estimated $12.1K sold.
Simplex Trading first reported a position in ADVM in Q1 2015 and held it in 27 quarters. The position peaked at $1.78M in Q2 2020. 58 funds tracked by Wall St. Rank hold ADVM as of Q2 2025.
- Simplex Trading reported no remaining Adverum Biotechnologies position as of Q2 2025 after selling out during the quarter.
- Simplex Trading sold 4,313 Adverum Biotechnologies shares in Q2 2025, an estimated $12.1K.
- Simplex Trading first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 27 quarters.
- Simplex Trading's Adverum Biotechnologies position peaked at $1.78M in Q2 2020.
- 58 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2025.
Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.